Published in Am J Surg Pathol on January 01, 2004
Tumor-induced osteomalacia. Endocr Relat Cancer (2011) 3.13
Myopericytoma: a unifying term for a spectrum of tumours that show overlapping features with myofibroma. A review of 14 cases. J Clin Pathol (2006) 1.72
Selective venous catheterization for the localization of phosphaturic mesenchymal tumors. J Bone Miner Res (2011) 1.45
Coauthorship in pathology, a comparison with physics and a survery-generated and member-preferred authorship guideline. MedGenMed (2004) 1.45
Fibroblast growth factor 23: state of the field and future directions. Trends Endocrinol Metab (2012) 1.21
Approach to the hypophosphatemic patient. J Clin Endocrinol Metab (2012) 1.16
Tumor localization and biochemical response to cure in tumor-induced osteomalacia. J Bone Miner Res (2013) 1.16
Epidemiology and classification of bone tumors. Clin Cases Miner Bone Metab (2012) 1.15
Regulation of phosphate transport by fibroblast growth factor 23 (FGF23): implications for disorders of phosphate metabolism. Pediatr Nephrol (2009) 1.14
Case records of the Massachusetts General Hospital. Case 33-2011. A 56-year-old man with hypophosphatemia. N Engl J Med (2011) 1.13
Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia. J Bone Miner Metab (2011) 1.06
Striking pathology gold: a singular experience with daily reverberations: sinonasal hemangiopericytoma (glomangiopericytoma) and oncogenic osteomalacia. Head Neck Pathol (2012) 1.05
Recent advances in renal phosphate handling. Nat Rev Nephrol (2010) 1.04
Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature. Chin J Cancer (2011) 1.02
A case of oncogenic osteomalacia due to occult nasal sinus tumor. Clin Cases Miner Bone Metab (2015) 0.95
Tumor-induced osteomalacia caused by primary fibroblast growth factor 23 secreting neoplasm in axial skeleton: a case report. Case Rep Endocrinol (2012) 0.95
Navigation-assisted surgery for bone and soft tissue tumors with bony extension. Clin Orthop Relat Res (2011) 0.94
Phosphaturic mesenchymal tumour of the sinonasal area: case report and review of the literature. Head Neck Oncol (2011) 0.93
Diagnostic Modalities for FGF23-Producing Tumors in Patients with Tumor-Induced Osteomalacia. Endocrinol Metab (Seoul) (2014) 0.92
Phosphaturic mesenchymal tumor, mixed connective tissue variant, of the mandible: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2009) 0.92
Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors. Mod Pathol (2016) 0.91
Hypophosphatemic rickets. Indian J Endocrinol Metab (2012) 0.90
Lymphatic vessels are present in phosphaturic mesenchymal tumours. Virchows Arch (2007) 0.90
Malignant phosphaturic mesenchymal tumor of the pelvis: A report of two cases. Oncol Lett (2014) 0.90
The hypoxia-inducible factor-1α activates ectopic production of fibroblast growth factor 23 in tumor-induced osteomalacia. Bone Res (2016) 0.89
Tumour-induced osteomalacia: a literature review and a case report. World J Surg Oncol (2016) 0.89
Using (18)F-FDG PET/CT to Detect an Occult Mesenchymal Tumor Causing Oncogenic Osteomalacia. Nucl Med Mol Imaging (2011) 0.88
Treatment of Recurrent Intracranial Hemangiopericytoma with SRC-Related Tyrosine Kinase Targeted Therapy: A Case Report. Case Rep Oncol (2010) 0.88
Calcium regulation and bone mineral metabolism in elderly patients with chronic kidney disease. Nutrients (2013) 0.87
The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed? Clin Orthop Relat Res (2013) 0.86
Quantitative ELISA-Like Immunohistochemistry of Fibroblast Growth Factor 23 in Diagnosis of Tumor-Induced Osteomalacia and Clinical Characteristics of the Disease. Dis Markers (2016) 0.85
Rickets: Part II. Pediatr Radiol (2012) 0.83
Tumor-Induced Osteomalacia: Increased Level of FGF-23 in a Patient with a Phosphaturic Mesenchymal Tumor at the Tibia Expressing Periostin. Case Rep Endocrinol (2014) 0.83
Sinonasal phosphaturic mesenchymal tumor: Case report and systematic review. Allergy Rhinol (Providence) (2014) 0.83
Phosphaturic mesenchymal tumor with chondromyxoid fibroma-like feature: an unusual morphological appearance. Skeletal Radiol (2011) 0.83
Renal phosphate wasting due to tumor-induced osteomalacia: a frequently delayed diagnosis. Kidney Int (2008) 0.82
Benefits of molecular pathology in the diagnosis of musculoskeletal disease : Part II of a two-part review: bone tumors and metabolic disorders. Skeletal Radiol (2009) 0.82
Phosphaturic Mesenchymal Tumor: 2 New Oral Cases and Review of 53 Cases in the Head and Neck. Head Neck Pathol (2015) 0.82
Tumor-induced osteomalacia. Expert Rev Endocrinol Metab (2009) 0.82
Ga68-DOTA Peptide PET/CT to Detect Occult Mesenchymal Tumor-Inducing Osteomalacia: A Case Series of Three Patients. Nucl Med Mol Imaging (2015) 0.81
ERG and FLI1 are useful immunohistochemical markers in phosphaturic mesenchymal tumors. Med Mol Morphol (2015) 0.81
Sinonasal phosphaturic mesenchymal tumor (mixed connective tissue variant): report of 2 cases. Am J Surg Pathol (2010) 0.81
Intracranial phosphaturic mesenchymal tumor, mixed connective tissue variant presenting without oncogenic osteomalacia. Surg Neurol Int (2012) 0.81
Hypophosphataemia-inducing mesenchymal tumour in the foot. BMJ Case Rep (2010) 0.80
Locally aggressive and multifocal phosphaturic mesenchymal tumors: two unusual cases of tumor-induced osteomalacia. Skeletal Radiol (2015) 0.80
Surgical treatment of tumor-induced osteomalacia: a retrospective review of 40 cases with extremity tumors. BMC Musculoskelet Disord (2015) 0.79
Phosphaturic mesenchymal tumor (mixed connective tissue variant): a case report with spectral analysis. Virchows Arch (2006) 0.79
Tumor-induced osteomalacia. Clin Rheumatol (2007) 0.79
Oncogenic osteomalacia due to phosphaturic mesenchymal tumor of the craniofacial sinuses. Clin Cases Miner Bone Metab (2011) 0.79
Tumor-Induced Osteomalacia. Transl Endocrinol Metab (2015) 0.79
Immunohistochemical and molecular detection of the expression of FGF23 in phosphaturic mesenchymal tumors including the non-phosphaturic variant. Diagn Pathol (2016) 0.78
Fibroblast growth factor receptor 1 (FGFR1) expression in phosphaturic mesenchymal tumors. Int J Clin Exp Pathol (2015) 0.78
En bloc resection for treatment of tumor-induced osteomalacia: a case presentation and a systematic review. World J Surg Oncol (2015) 0.78
Reports of 17 Chinese patients with tumor-induced osteomalacia. J Bone Miner Metab (2016) 0.77
Tumor-induced osteomalacia due to a recurrent mesenchymal tumor overexpressing several growth factor receptors. Endocrinol Diabetes Metab Case Rep (2015) 0.77
Phosphaturic mesenchymal tumor: two contrasting cases. Skeletal Radiol (2014) 0.77
Phosphaturic Mesenchymal Tumor Involving the Head and Neck: A Report of Five Cases with FGFR1 Fluorescence In Situ Hybridization Analysis. Head Neck Pathol (2016) 0.77
Mesenchymal phosphaturic tumour: early detection of recurrence. BMJ Case Rep (2014) 0.76
Diffuse pain, hypophosphatemia, and a subcutaneous nodule. J Am Acad Dermatol (2007) 0.76
Oncogenic osteomalacia illustrating the effect of fibroblast growth factor 23 on phosphate homeostasis. Clin Kidney J (2012) 0.76
Musculoskeletal oncogenic osteomalacia-An experience from a single centre in South India. J Orthop (2017) 0.75
Oncogenic osteomalacia caused by occult nasal mesenchymal tumor: a monster in the cave. Oxf Med Case Reports (2015) 0.75
Resolution of severe oncogenic hypophosphatemic osteomalacia after resection of a deeply located soft-tissue tumour. Curr Oncol (2009) 0.75
Oncogenic osteomalacia associated with mesenchymal tumor in the middle cranial fossa: a case report. J Med Case Rep (2012) 0.75
Identifying the culprit lesion in tumor induced hypophosphatemia, the solution of a clinical enigma. Endocrine (2016) 0.75
CD56 may be a more useful immunohistochemical marker than somatostatin receptor 2A for the diagnosis of phosphaturic mesenchymal tumors. Int J Clin Exp Pathol (2015) 0.75
Tumor-induced Osteomalacia Caused by a Parotid Tumor. Intern Med (2017) 0.75
A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia. BMC Musculoskelet Disord (2017) 0.75
Anterior Skull Base Glomangioma-Induced Osteomalacia. J Neurol Surg Rep (2017) 0.75
Revision hip arthroplasty following recurrence of a phosphaturic mesenchymal tumor. J Surg Case Rep (2013) 0.75
Oncogenic hypophosphatemic osteomalacia: From the first signal of disease to the first signal of healthy. Int J Surg Case Rep (2016) 0.75
Possibility of D2-40 as a diagnostic and tumor differentiation-suggestive marker for some of phosphaturic mesenchymal tumors. Int J Clin Exp Pathol (2015) 0.75
Sinonasal Phosphaturic Mesenchymal Tumor: A Rare and Misinterpreted Entity. J Neurol Surg Rep (2015) 0.75
Effective localization in tumor-induced osteomalacia using (68)Ga-DOTATOC-PET/CT, venous sampling and 3T-MRI. Endocrinol Diabetes Metab Case Rep (2017) 0.75
Diagnostic importance of contrast enhanced (18)F-fluorodeoxyglucose positron emission computed tomography in patients with tumor induced osteomalacia: Our experience. Indian J Nucl Med (2016) 0.75
Malignant phosphaturic mesenchymal tumor with pulmonary metastasis: A case report. Medicine (Baltimore) (2017) 0.75
Phosphaturic mesenchymal tumour mixed connective tissue variant: report of three cases with unusual histological findings. Int J Clin Exp Pathol (2015) 0.75
Tumour induced osteomalacia due to a sinonasal hemangiopericytoma: A case report. World J Clin Cases (2013) 0.75
Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients. BMC Musculoskelet Disord (2017) 0.75
Localization of Oncogenic Osteomalacia by Systemic Venous Sampling of Fibroblast Growth Factor 23. Yonsei Med J (2017) 0.75
Oncogenic osteomalacia: role of Ga-68 DOTANOC PET/CT scan in identifying the culprit lesion and its management. Br J Radiol (2017) 0.75
Phosphaturic mesenchymal tumor of the tibia with oncogenic osteomalacia in a teenager. Pediatr Radiol (2015) 0.75
Heritable and acquired disorders of phosphate metabolism: Etiologies involving FGF23 and current therapeutics. Bone (2017) 0.75
Selective blood sampling for FGF-23 in tumor-induced osteomalacia. Endocrinol Diabetes Metab Case Rep (2017) 0.75
Tumor-induced osteomalacia. Bone Rep (2017) 0.75
Tumor-associated FGF-23-induced hypophosphatemic rickets in children: a case report and review of the literature. Pediatr Nephrol (2014) 0.75
Founders lecture 2007: Metabolic bone disease: what has changed in 30 years? Skeletal Radiol (2009) 0.75
Oncogenic Osteomalacia: An Approach to Diagnosis with a Case Report. J Clin Diagn Res (2017) 0.75
Successful CT guided cryoablation of phosphaturic mesenchymal tumor in the soft tissues causing tumor-induced osteomalacia: a case report. Skeletal Radiol (2016) 0.75
Phosphaturic mesenchymal tumor (PMT): exceptionally rare disease, yet crucial not to miss. Autops Case Rep (2017) 0.75
Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol (2002) 20.87
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89
Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med (2003) 8.87
A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol (2004) 8.29
Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet (2006) 7.53
Molecular characterisation of soft tissue tumours: a gene expression study. Lancet (2002) 7.05
Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol (2005) 5.53
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48
Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol (2010) 4.26
Lipoma of the oral and maxillofacial region: Site and subclassification of 125 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2004) 3.96
The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol (2004) 3.84
Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol Cell Biol (2007) 3.73
FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest (2003) 3.60
Gastrointestinal stromal tumors: radiologic features with pathologic correlation. Radiographics (2003) 3.54
Confocal laser endomicroscopy in Barrett's esophagus and endoscopically inapparent Barrett's neoplasia: a prospective, randomized, double-blind, controlled, crossover trial. Gastrointest Endosc (2009) 3.46
Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet (2010) 3.37
Discordant architectural and cytological features in cutaneous sebaceous neoplasms--a classification dilemma: report of 5 cases. Am J Dermatopathol (2009) 3.37
The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Low Genit Tract Dis (2012) 3.19
Extradigital glomus tumors: a 20-year experience. Mayo Clin Proc (2006) 3.13
Human cancers express a mutator phenotype. Proc Natl Acad Sci U S A (2006) 3.11
Occurrence of other malignancies in patients with gastrointestinal stromal tumors. Semin Diagn Pathol (2006) 3.09
A critical analysis of the accuracy, reproducibility, and clinical utility of histologic endometrial dating in fertile women. Fertil Steril (2004) 3.08
Pigmented villonodular synovitis: radiologic-pathologic correlation. Radiographics (2008) 3.06
Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney: a clinicopathologic and immunohistochemical analysis of 11 cases. Am J Surg Pathol (2002) 3.03
Autophagy inhibition and antimalarials promote cell death in gastrointestinal stromal tumor (GIST). Proc Natl Acad Sci U S A (2010) 3.00
Diagnosis of gastrointestinal stromal tumors: a consensus approach. Int J Surg Pathol (2002) 2.95
Genetics of osteoporosis. Endocr Rev (2002) 2.91
Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors. J Clin Oncol (2002) 2.85
Determination of stromal signatures in breast carcinoma. PLoS Biol (2005) 2.84
EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene. Genes Chromosomes Cancer (2010) 2.81
A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J Clin Invest (2007) 2.79
Multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol (2012) 2.70
Pseudosarcomatous myofibroblastic proliferations of the bladder: a clinicopathologic study of 42 cases. Am J Surg Pathol (2006) 2.62
Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia (2005) 2.62
Pleomorphic hyalinizing angiectatic tumor: analysis of 41 cases supporting evolution from a distinctive precursor lesion. Am J Surg Pathol (2004) 2.58
Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163. Mod Pathol (2005) 2.57
KIT gene mutations and copy number in melanoma subtypes. Clin Cancer Res (2008) 2.57
Spindle cell (sarcomatoid) carcinomas of the larynx: a clinicopathologic study of 187 cases. Am J Surg Pathol (2002) 2.48
Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23. Endocrinology (2005) 2.46
Epithelioid hemangioendothelioma of soft tissue: a proposal for risk stratification based on 49 cases. Am J Surg Pathol (2008) 2.46
Abdominal lymphangiomas: imaging features with pathologic correlation. AJR Am J Roentgenol (2004) 2.42
Gastrointestinal schwannomas: CT features with clinicopathologic correlation. AJR Am J Roentgenol (2005) 2.39
Reactive nodular fibrous pseudotumor of the gastrointestinal tract and mesentery: a clinicopathologic study of five cases. Am J Surg Pathol (2003) 2.35
Malignant mixed epithelial and stromal tumor of the kidney: report of the first male case. Int J Urol (2012) 2.33
Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol (2004) 2.33
Biomarker system for studying muscle, stem cells, and cancer in vivo. FASEB J (2009) 2.31
A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive. J Clin Endocrinol Metab (2005) 2.30
Whole-slide imaging digital pathology as a platform for teleconsultation: a pilot study using paired subspecialist correlations. Arch Pathol Lab Med (2009) 2.30
Imaging of synovial chondromatosis with radiologic-pathologic correlation. Radiographics (2007) 2.30
Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma. Clin Cancer Res (2003) 2.28
Treatment and outcome of 82 patients with angiosarcoma. Ann Surg Oncol (2007) 2.25
Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice. Proc Natl Acad Sci U S A (2011) 2.24
Neuroendocrine carcinomas (carcinoid tumor) of the testis. A clinicopathologic and immunohistochemical study of ten cases. Am J Clin Pathol (2003) 2.21
Frequent truncating mutations of STAG2 in bladder cancer. Nat Genet (2013) 2.20
Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects. Biochem Biophys Res Commun (2010) 2.20
Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations. Hum Pathol (2002) 2.19
Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases. Am J Surg Pathol (2005) 2.19
Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol (2005) 2.17
Neurothekeoma: an analysis of 178 tumors with detailed immunohistochemical data and long-term patient follow-up information. Am J Surg Pathol (2007) 2.15
Does the panel of cytokeratin 20 and androgen receptor antibodies differentiate desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma? J Cutan Pathol (2008) 2.15
Mutations of the BRAF gene in benign and malignant melanocytic lesions. J Invest Dermatol (2003) 2.14
A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys (2006) 2.13
Operative management of sacral chordoma. J Bone Joint Surg Am (2005) 2.12
NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract. Am J Surg Pathol (2008) 2.12
Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor. Cancer Discov (2013) 2.11
A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci U S A (2006) 2.08
Cutaneous adenolipoma: extending the spectrum of changes in the lipomatous and epithelial components. Am J Dermatopathol (2011) 2.07
Tuberous sclerosis-associated lesions of the kidney, brain, and skin are angiogenic neoplasms. J Am Acad Dermatol (2002) 2.05
Dermatofibrosarcoma protuberans: MR imaging features. AJR Am J Roentgenol (2002) 2.04
A histological and immunohistochemical study of the subsynovial connective tissue in idiopathic carpal tunnel syndrome. J Bone Joint Surg Am (2004) 2.04
Malignant gastrointestinal neuroectodermal tumor: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of 16 cases with a reappraisal of clear cell sarcoma-like tumors of the gastrointestinal tract. Am J Surg Pathol (2012) 2.03
A case of renal osteodystrophy with unexpected serum intact parathyroid hormone concentrations. Clin Chem (2009) 2.01
A clinician's guide to X-linked hypophosphatemia. J Bone Miner Res (2011) 2.00
Neoadjuvant chemotherapy for osteosarcoma of the extremity: intensification of preoperative treatment does not increase the rate of good histologic response to the primary tumor or improve the final outcome. J Pediatr Hematol Oncol (2003) 1.99
Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern. Proc Natl Acad Sci U S A (2007) 1.97
Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms. Mod Pathol (2008) 1.95
Spindle cell lesions of the adult prostate. Mod Pathol (2007) 1.94
TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies. Am J Surg Pathol (2007) 1.94
Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system. Am J Surg Pathol (2003) 1.93
A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis. J Clin Endocrinol Metab (2005) 1.93
Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation. Am J Hum Genet (2004) 1.92
Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection. Am J Surg Pathol (2004) 1.92
Vascular malformations and hemangiolymphangiomas of the gastrointestinal tract: morphological features and clinical impact. Int J Clin Exp Pathol (2011) 1.91
Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia. J Clin Endocrinol Metab (2006) 1.91
Spindle cell lipoma-like tumor, solitary fibrous tumor and myofibroblastoma of the breast: a clinico-pathological analysis of 13 cases in favor of a unifying histogenetic concept. Virchows Arch (2002) 1.91
Superficial acral fibromyxoma: a clinicopathological analysis of 32 tumors including 4 in the heel. J Cutan Pathol (2008) 1.91
Primary cutaneous cribriform apocrine carcinoma: a clinicopathologic and immunohistochemical study of 26 cases of an under-recognized cutaneous adnexal neoplasm. J Am Acad Dermatol (2009) 1.89
KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs). Semin Diagn Pathol (2006) 1.88
Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma. J Cell Biol (2004) 1.88